1. WHO. Library cataloguing-in-publication data global status report on noncommunicable diseases 2014. 1. Chronic disease - prevention and control.
2. Chronic disease - epidemiology. 3. Chronic disease - mortality. 4. Cost of illness. 5. Delivery of health care. Geneva: World Health Organization; 2014.
3. Raubenheimer D.; Rothman J. M.; Pontzer H.; Simpson S. J. Macronutrient contributions of insects to the diets of hunter-gatherers: A geometric analysis. J. Hum. Evol. 2014, 71, 70-76.
4. Chassaing B., Van de Wiele T., De Bodt J., Marzorati M., Gewirtz A. T. Dietary emulsifers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut. 2017 Aug; 66 (8): 1414-1427.
5. Calder P. C. Polyunsaturated fatty acids and inflammation. Biochem. Soc. Trans. 2005, 33, 423-427.
6. De Menezes E.V.A., Sampaio H.A.C., Carioca A.A.F., Parente N.A., Brito F.O., Moreira T. M.M., de Souza A. C.C., Arruda S. P.M. Influence of Paleolithic diet on anthropometric markers in chronic diseases: systematic review and meta-analysis Nutrition Journal volume 18, Article number: 41 (2019), 1-10.
7. WHO. Diet, nutrition and the prevention of chronic diseases. Geneva: World Health Organization; 2003.
8. Otten J., Ryberg M., Mellberg C., Andersson T., Chorell E., Lindahl B., Larsson C., Holst J. J., Olsson T. Postprandial levels of GLP-1, GIP and glucagon after 2 years of weight loss with a Paleolithic diet: A randomised controlled trial in healthy obese women. Eur J Endocrinol. 2019 Jun 1;180 (6): 417-427.
9. Otten J., Andersson J., Ståhl J., Stomby A., Saleh A., Waling M., Ryberg M., Hauksson J., Svensson M., Johansson B., Olsson T. Exercise Training Adds Cardiometabolic Benefts of a Paleolithic Diet in Type 2 Diabetes Mellitus. J Am Heart Assoc. 2019 Jan 22; 8 (2).
10. Manheimer E. W., Zuuren E. J.V., Fedororowicz Z. Paleolithic nutrition for metabolic syndrome: systematic review and meta-analysis. Am J Clin Nutr. 2015; 102: 922-32.
11. Otten J., Stomby A., Waling M., Isaksson A., Tellstrom A., Lundin-Olsson L., et al. Benefts of a Paleolithic diet with and without supervised exercise on fat mass, insulin sensitivity, and glycemic control: a randomized controlled trial in individuals with type 2 diabetes. Diabetes Metab Res Rev. 2017; 33 (1).
12. Mellberg C., Sandberg S., Ryberg M., Eriksson M., Brage S., Larsson C., et al. Long-term effects of a Palaeolithic-type diet in obese postmenopausal women: a 2-year randomized trial. Eur J Clin Nutr. 2014;.68 (3): 350-7.
13. Ghaedi E., Mohammadi M., Mohammadi H., Ramezani-Jolfaie N., Malekzadeh J., Hosseinzadeh M., Salehi-Abargouei A. Effects of a Paleolithic Diet on Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv Nutr. 2019 Jul 1; 10 (4): 634-646.
14. Smith M. M., Trexler E. T., Sommer A. J., Starkoff B. E., Devor S. T. Unrestricted Paleolithic diet is associated with unfavorable changes to blood lipids in healthy subjects. Int J Exerc Sci. 2014; 7 (2): 128-39.
15. Otten J., Mellberg C., Ryberg M., Sandberg S., Kullberg J., Lindahl B., et al. Strong and persistent effect on liver fat with a Paleolithic diet during a twoyear intervention. Int J Obes. 2016; 40 (5): 747-53.
16. Abbott R. D., Sadowski A., Alt A. G. Effcacy of the Autoimmune Protocol Diet as Part of a Multidisciplinary, Supported Lifestyle Intervention for Hashimoto's Thyroiditis. Cureus. 2019 Apr 27; 11 (4): 4556.
17. Mosca A., Leclerc M., Hugot J. P. Gut microbiota diversity and human diseases: should we reintroduce key predators in our ecosystem? Front. Microbiol. 2016; 7: 455.
18. Cani P. D., Jordan B. F. Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer. Nat Rev Gastroenterol Hepatol. 2018; 15 (11): 671-82.
19. Obregon-Tito A.J., Tito R.Y., Metcalf J., Sankaranarayanan K., Clemente J.C., Ursell L. K., et al. Subsistence strategies in traditional societies distinguish gut microbiomes. Nat Commun. 2015; 6: 6505.
20. He Y, Wu W, Zheng HM, Li P, McDonald D, Sheng HF, et al. Regional variation limits applications of healthy gut microbiome reference ranges and disease models. NatMed. 2018;24(10): 1532-5.
21. Barone M., Turroni S., Rampelli S., Soverini M., D'Amico F., Biagi E., Brigidi P., Troiani E., Candela M. Gut microbiome response to a modern Paleolithic diet in a Western lifestyle context. PLoS One. 2019 Aug 8; 14 (8).
22. Tang W. H., Wang Z., Li X. S., Fan Y., Li D. S., Wu Y. et al (2017) Increased Trimethylamine N-oxide portends high mortality risk independent of glycemic control in patients with type 2 diabetes mellitus. Clin Chem 63 (1): 297-306.
23. Tang W. H.W., Wang Z., Fan Y., Levison B., Hazen J. E., Donahue L. M. et al (2014) Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refning the gut hypothesis. Jam Coll Cardiol. 64 (18): 1908-1914.
24. Genoni A., Christophersen C. T., Lo J., Coghlan M., Boyce M. C., Bird A. R., Lyons-Wall P., Devine A. Long-term Paleolithic diet is associated with lower resistant starch intake, different gut microbiota composition and increased serum TMAO concentrations. Eur J Nutr. 2019 Jul 5.
25. Cox A. J., West N. P., Cripps A. W. Obesity, inflammation, and the gutmicrobiota. Lancet Diabetes Endocrinol. 2015, 3, 207-215.
26. Desai M. S., Seekatz A. M., Koropatkin N. M., Kamada N., Hickey C. A., Wolter M., Pudlo N. A., Kitamoto S., Terrapon N., Muller A. et al. A dietary fber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 2016, 167, 1339-1353.
27. Ng S.C., Shi H.Y., Hamidi N., Underwood F.E., Tang W., Benchimol E.I., Panaccione R., Ghosh S., Wu J. C.Y., Chan F. K.L., Sung J. J.Y., Kaplan G. G. Lancet. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018 Dec 23; 390 (10114): 2769-2778.
28. Castro F., de Souza H. S.P. Dietary Composition and Effects in Inflammatory Bowel Disease. Nutrients. 2019 Jun 21; 11 (6).
29. Thorburn A. N., Macia L., Mackay C. R. Diet, Metabolites, and ‘Western-Lifestyle’ Inflammatory Diseases. Immunity (2014) 40: 833-42.
30. Marsman K. E., McBurney M. I. Dietary fber increases oxidative metabolism in colonocytes but not in distal small intestinal enterocytes isolated from rats. J Nutr. (1995) 125: 273-82.
31. Kelly C. J., Zheng L., Campbell E. L., Saeedi B., Scholz C. C., Bayless A. J., et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe (2015) 17: 662-71.
32. Nickerson K.P., Chanin R., McDonald C. Deregulation of intestinal antimicrobial defense by the dietary additive, maltodextrin. Gut Microbes. 2015, 6: 78-83.
33. Longman R. S., Littman D. R. The functional impact of the intestinal microbiome on mucosal immunity and systemic autoimmunity. Curr Opin Rheumatol. 2015, 27: 381-387.
34. Konijeti G. G., Kim N., Lewis J. D., Groven S., Chandrasekaran A., Grandhe S., Diamant C., Singh E., Oliveira G., Wang X., Molparia B., Torkamani A. Effcacy of the Autoimmune Protocol Diet for Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017 Nov; 23 (11): 2054-2060.
35. Tóth C., Daboczi A., Howard M., Miller N. J. Clemens. Crohn’s disease successfully treated with the paleolithic ketogenic diet. Int J Case Rep Images2016; 7: 570-8.